Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

The success of CAR-T cells for treating acute myeloid leukaemia (AML) is hampered by toxicity to normal cells and low CAR-T cell persistence. Here, the authors show that the demethylating compound 5′-Azacitdine increases anti-CD123 CAR-T cell cytotoxicity against AML.

Saved in:
Bibliographic Details
Main Authors: Nadia El Khawanky, Amy Hughes, Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Cornelius Miething, Angel F. Lopez, Michael P. Brown, Justus Duyster, Lutz Hein, Markus G. Manz, Timothy P. Hughes, Deborah L. White, Agnes S. M. Yong, Robert Zeiser
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Science
Q
Online Access:https://doaj.org/article/fe5a9441efac4b52a10770a66f35954d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/fe5a9441efac4b52a10770a66f35954d

Similar Items